Surface Stimulation for Female Sexual Dysfunction
| Status: | Completed |
|---|---|
| Conditions: | Women's Studies |
| Therapuetic Areas: | Reproductive |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/17/2018 |
| Start Date: | February 2016 |
| End Date: | March 2018 |
Female sexual dysfunction, including sexual arousal disorder, has a significant clinical
impact, affecting millions of women in the United States alone. Peripheral nerve stimulation,
such as posterior tibial nerve stimulation (PTNS) and dorsal genital nerve stimulation (DGNS)
can modulate neural circuits for bladder and fecal continence. The investigators hypothesize
that periodic DGNS and PTNS will modulate autonomic neural circuits and promote improvements
in sexual function in women with sexual arousal disorder. Subjects will be randomized to
receive one of the stimulation approaches. Subjects will have weekly 30-minute sessions
across twelve weeks.
impact, affecting millions of women in the United States alone. Peripheral nerve stimulation,
such as posterior tibial nerve stimulation (PTNS) and dorsal genital nerve stimulation (DGNS)
can modulate neural circuits for bladder and fecal continence. The investigators hypothesize
that periodic DGNS and PTNS will modulate autonomic neural circuits and promote improvements
in sexual function in women with sexual arousal disorder. Subjects will be randomized to
receive one of the stimulation approaches. Subjects will have weekly 30-minute sessions
across twelve weeks.
Inclusion Criteria:
- Adult women ≥ 18 years of age
- Sexually active ≥ 1 time per month (≥ 2 times per month preferred)
- Score of 19 or less on a 6-question set of the Female Sexual Function Index (FSFI)
survey
- Neurologically stable
- Ambulatory
- Capable of giving informed consent
- English speaking
- Capable and willing to follow study procedures
Exclusion Criteria:
- Men
- Women ≤ 17 years of age
- Pregnant or planning to get pregnant during the study period
- Clinically diagnosed neurological bladder dysfunction
- Prior experience with PTNS or DGNS
- Current use of transcutaneous electrical nerve stimulation (TENS) on pelvis, back, or
legs
- Implanted pacemaker, defibrillator, spinal cord stimulator, or sacral root stimulator
- Taking flibanserin
- Taking any investigational drug
- History of neurologic diseases or impairments
- Any other factors that the investigators feel would place the patient at increased
risk from this study
We found this trial at
1
site
1500 E Medical Center Dr
Ann Arbor, Michigan 48109
Ann Arbor, Michigan 48109
(734) 936-4000
University of Michigan Health System The University of Michigan is home to one of the...
Click here to add this to my saved trials
